Biliary atresia

1750-1172-1-28 1750-1172 Review Biliary atresia Chardot Christophe christophe.chardot@hcuge.ch

Service de chirurgie pédiatrique, Hôpital Cantonal Universitaire de Genève, Rue Willi Donzé 6, CH 1205 Geneve, Switzerland

Orphanet Journal of Rare Diseases 1750-1172 2006 1 1 28 http://www.OJRD.com/content/1/1/28 16872500 10.1186/1750-1172-1-28 06 6 2006 26 7 2006 26 7 2006 2006 Chardot; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Biliary atresia (BA) is a rare disease characterised by a biliary obstruction of unknown origin that presents in the neonatal period. It is the most frequent surgical cause of cholestatic jaundice in this age group. BA occurs in approximately 1/18,000 live births in Western Europe. In the world, the reported incidence varies from 5/100,000 to 32/100,000 live births, and is highest in Asia and the Pacific region. Females are affected slightly more often than males. The common histopathological picture is one of inflammatory damage to the intra- and extrahepatic bile ducts with sclerosis and narrowing or even obliteration of the biliary tree. Untreated, this condition leads to cirrhosis and death within the first years of life. BA is not known to be a hereditary condition. No primary medical treatment is relevant for the management of BA. Once BA suspected, surgical intervention (Kasai portoenterostomy) should be performed as soon as possible as operations performed early in life is more likely to be successful. Liver transplantation may be needed later if the Kasai operation fails to restore the biliary flow or if cirrhotic complications occur. At present, approximately 90% of BA patients survive and the majority have normal quality of life.

Disease name

Biliary atresia

Definition

Biliary atresia (BA) is a rare disease characterised by a biliary obstruction of unknown origin that presents in the neonatal period 1.

Background

BA is the most frequent surgical cause of cholestatic jaundice in neonates. The common histopathological picture is one of inflammatory damage to the intra- and extrahepatic bile ducts with sclerosis and narrowing or even obliteration of the biliary tree 2. Untreated, this condition leads to cirrhosis and death within the first years of life. Surgical treatment usually involves an initial attempt to restore bile flow: the Kasai portoenterostomy 3, which is performed as soon after diagnosis as possible. Later, liver transplantation may be needed if the Kasai operation fails to restore the biliary flow or if cirrhosis complications occur 4. BA remains the most common indication for paediatric liver transplantation worldwide.

Epidemiology

The reported incidence of BA varies from 5/100,000 live births in The Netherlands 5, 5.1/100,000 in France 6, 6/100,000 in the British Isles 7, 6.5/100,000 in Texas 8, 7/100,000 in Victoria Australia 9, 7.4/100,000 in Atlanta USA 10 and in Japan 11, 10.6/100,000 in Hawaii 12, to 32/100,000 in French Polynesia 13. Incidence of BA is highest in Asia and the Pacific region. Females are affected slightly more often than males. Although some studies of time- and space-time distribution of BA cases have suggested seasonal variation and clustering of cases 8910, these results have not been confirmed by larger studies 56, 1415.

Anatomical forms

Two different forms of BA have been identified 16:

• Syndromic BA (~10%), associated with various congenital anomalies such as polysplenia, asplenia, cardiac or intra abdominal defects (situs inversus, pre-duodenal portal vein, absence of retro-hepatic inferior vena cava, intestinal malrotation).

• Non-syndromic BA (~90%), in which BA is an isolated anomaly.

Several surgical classifications of BA have been proposed. The French classification is based on the anatomical pattern of the extrahepatic biliary tract remnant (Table 1) 1718.

Table 1

Anatomical types of biliary atresia (BA)

French classification

Frequency

Description

Upper level of obstruction of the extrahepatic bile ducts

US/UK/Japanese classification

Type 1

~3%

Atresia limited to the common bile duct

Common bile duct

Type 1

Type 2

~6%

Cyst in the liver hilum communicating with dystrophic intrahepatic bile ducts

Hepatic duct

Type 2

Type 3

19%

Gallbladder, cystic duct and common bile duct patent

Porta hepatis

Type 3

Type 4

72%

Complete extrahepatic BA

Porta hepatis

Type 3

Aetiology

The aetiology of BA remains unknown. Some cases seem to be related to abnormal morphogenesis of bile ducts occurring early in gestation, while others appear to arise from later damage to normally developing bile ducts.

There are several strands of evidence to suggest that even in non-syndromic BA, the onset takes place early in gestation. Antenatal ultrasonography allows detection of those forms of BA that show cystic changes 19. In a series of 10 infants detected antenatally, most were non-syndromic and the first abnormal scans were observed at about 20 weeks of gestation 20. In one study on serial digestive enzyme sampling in amniotic fluid, gamma-glutamyl transpeptidase (gamma-GTs) levels were found significantly low as early as 18 weeks of gestation in infants born with non-syndromic BA, providing strong evidence of biliary obstruction at this term of gestation 21.

Human embryo studies have also revealed similarities between the appearance of developing bile ducts during the first trimester of pregnancy and the residual ductules seen at porta hepatis level in BA patients; thus, it was suggested that some cases of BA may result from alteration of the remodelling process of the bile ducts originating from the ductal plate membrane 22. The persistence of primitive foetal-type bile ducts that leak bile into surrounding tissues and induce a secondary inflammatory reaction in utero has also been suggested. Recent studies have focused on normal and altered bile duct morphogenesis 2324 and the initiation of hepatic fibrosis 25.

The role of viruses has been extensively studied. An association of BA with cytomegalovirus 2627, respiratory syncitial virus 28, Epstein-Barr virus 29 and human papilloma virus 30 has been reported. In contrast, no association with hepatitis A, B and C viruses has been found 3132. Reovirus type 3 can cause cholangitis resembling BA in mice 33 and may be associated with spontaneous BA in the rhesus monkey 34. In human neonates, the association of reovirus type 3 and BA has been suggested in several studies 35363738 but not supported in others 394041. Rotavirus type A can cause biliary obstruction in newborn mice, mimicking BA 42; deleterious effects of rotavirus infection in mice can be prevented by interferon alpha 43. In humans, the role of rotavirus type C in the aetiology of BA remains controversial 4445.

Several observations suggest that a genetic component plays a role in the pathogenesis of BA, although this is probably only one of multiple factors. Familial cases of BA have been reported 4647484950 although discordant sets of monozygotic twins have also been observed 515253. Variations in the incidence of BA among different races have been reported from Hawaii 12 and Atlanta, USA 10. The incidence of HLA B12 and haplotypes A9-B5 and A28-B35 was found to be higher in infants with BA compared to a control group in one UK study 54.

Clinical features

After birth, the clinical triad of BA is:

• Jaundice (conjugated hyperbilirubinemia lasting beyond two weeks of life)

• Acholic (white) stools and dark urine (Figure 1)

Figure 1

Acholic white stools

Acholic white stools.

• Hepatomegaly

The general condition of the child is usually good. There is no failure to thrive, at least in the first months. Thereafter, weight loss and irritability develop, accompanied by increasing levels of jaundice. Later signs include splenomegaly (suggesting portal hypertension), ascites and haemorrhage (which can be intracranial, gastrointestinal or from the umbilical stump) due to impaired absorption of vitamin K. Untreated, this condition leads to cirrhosis and death within the first years of life.

Diagnosis and diagnostic methods

Since early diagnosis appears essential for effective surgical treatment 1718, 555657, every case of neonatal jaundice lasting more than two weeks should be investigated and biliary atresia actively excluded 5859. Diagnosis is made on the basis of the clinical manifestations and is supported by the following diagnostic methods:

• Ultrasonography

Ultrasonography of the liver is performed after 12 hours of fasting (with an IV dextrose infusion). BA is suspected when the gallbladder is shrunk despite fasting, when the liver hilum appears hyperechogenic ("triangular cord sign") or when there is a cyst at the liver hilum. There should be no evidence of bile duct dilatation. Syndromic BA infants may show other features such as multiple spleens, preduodenal portal vein, absence of retrohepatic vena cava or abdominal situs inversus.

• Cholangiography

When the gallbladder seems normal on ultrasonography scans, cholangiography is needed to assess the morphology and patency of the biliary tree. A cholangiogram can be obtained percutaneously (puncture of the gallbladder), endoscopically (ERCP) or at operation.

• Liver biopsy

The main histological features suggestive of BA are bile plugs, ductular proliferation, portal oedema and/or fibrosis. As with any other cause of neonatal cholestasis, giant cell transformation may be observed.

• Others

Biochemical liver function tests show cholestasis (with elevated cholesterol and gamma-GTs). Hepatobiliary scintigraphy (e.g. HIDA scans) demonstrates a failure of excretion of the radioisotope into the intestine, but this feature can also be observed in any severe neonatal cholestasis 60.

Differential diagnosis

Medical causes of neonatal cholestasis must be excluded. The main differential diagnose are: Alagille syndrome, sclerosing cholangitis with neonatal onset, alpha-1-antitrypsin deficiency, cystic fibrosis, and more rarely progressive familial intrahepatic cholestasis (PFIC).

In most cases, diagnosis of BA can be strongly suspected after consideration of the clinical features, ultrasonography scans and exclusion of the main medical causes of neonatal cholestasis. Cholangiography and/or liver biopsy are indicated only in cases where the diagnosis remains uncertain, especially when the gallbladder seems normal on ultrasonography scans 6162.

Antenatal diagnosis

Antenatal diagnosis of BA remains exceptional. BA Types 1 and 2, which are rare, can be suspected on antenatal ultrasonography scans when a cystic structure is detected in the liver hilum 1963. Postnatal examination has to distinguish the cystic form of BA, which requires urgent surgery, from a choledocal cyst for which surgery may be delayed.

Non-visualization of the foetal gallbladder in early pregnancy (14–16 weeks gestation) may be associated with severe foetal anomalies, including polymalformation syndromes, chromosomal aberrations, cystic fibrosis 64: amniocentesis is recommended for cystic fibrosis screening, hepatic enzymes tests and chromosomal analysis. Gallbladder may be visualised later in pregnancy, suggesting a delay in its recanalisation process. When the gallbladder remains undetectable after birth, the possibility that the patient has BA has to be carefully investigated. The incidence of agenesis of the gallbladder (without BA) is estimated at approximately 1/6000 pregnancies 64.

Features of polysplenia syndrome may be detected by antenatal ultrasonography. They may be part of a cardiosplenic syndrome whose prognosis depends mainly on the underlying cardiopathy 6566. Interrupted inferior vena cava may be isolated and benign 67. However, neonates with features of the polysplenia syndrome should be carefully followed in order to rule out BA.

Management

The current management of BA patients involves two steps:

• Kasai operation (in the neonatal period), which aims to restore bile flow.

• Liver transplantation in children for whom the Kasai operation has failed in its primary aim or for whom complications of biliary cirrhosis have supervened.

• The Kasai operation: hepatoporto-enterostomy

After transverse supra-umbilical incision and laparotomy, diagnosis is confirmed by inspection of the liver and biliary tract. In most cases (type 4: complete extrahepatic BA), diagnosis is obvious with a cholestatic or fibrotic liver and a shrunken fibrotic gallbladder (Figure 2). If the gallbladder is still patent or if there is a cyst at the liver hilum, the colour of their content is noted and cholangiography is performed. Features of polysplenia syndrome, as well as any other intra-abdominal anomaly, are noted. The portal pressure can be measured through a small catheter introduced via the umbilical vein. After section of the falciform, left and right triangular ligaments, the liver is exteriorised out of the abdominal cavity. The entire extrahepatic biliary tree is excised together with the fibrous tissue occupying the space between the left and right branches of the portal vein at the level of the porta hepatis. A 45 cm Roux-en-Y loop is prepared and passed through the mesocolon to the liver hilum. An anastomosis is fashioned between the cut edge of the transsected tissue in the porta hepatis and the antimesenteric side of the Roux loop (Figure 3). A liver biopsy is performed.

Figure 2

Operative view of complete extrahepatic biliary atresia

Operative view of complete extrahepatic biliary atresia.

Figure 3

Hepatoporto-enterostomy (Kasai procedure) [68]*

Hepatoporto-enterostomy (Kasai procedure) [68]*. * Valayer J, Chardot C: Atrésie des voies biliaires. Encycl Méd Chir (Elsevier SAS, Paris, All rights reserved), Techniques chirurgicales – appareil digestif (40–890); 2002: p. 12. Reproduction authorized by Elsevier Masson SAS.

Many technical variants are possible, according to the anatomical pattern of the biliary remnant:

• Type 1 BA: cholecysto-enterostomy, or hepatico-enterostomy.

• Type 2 BA: cysto-enterostomy. This operation can be performed only if the hilar cyst communicates with the dystrophic intrahepatic bile ducts (as shown at cholangiography).

• Type 3 BA: hepatoporto-cholecystostomy. The patent galbladder, cystic duct and common bile duct are preserved. The gallbladder is mobilised with preservation of its pedicle. An anastomosis is performed between the gallbladder and the transsected tissue in the porta hepatis (Figure 4). Since there is no direct contact between the porta hepatis and the intestine, this operation reduces the risk of post-operative cholangitis 57. Its specific complications, however, are bile leaks and post-operative biliary ascites caused by kinking and obstruction of the cystic duct and the common bile duct 697071.

Figure 4

Hepatoporto-cholecystostomy [68]*

Hepatoporto-cholecystostomy [68]*. * Valayer J, Chardot C: Atrésie des voies biliaires. Encycl Méd Chir (Elsevier SAS, Paris, All rights reserved), Techniques chirurgicales – appareil digestif (40–890); 2002: p. 12. Reproduction authorized by Elsevier Masson SAS.

• Post-operative course

Post-operatively, different drugs have been proposed either for reducing the inflammatory process at the liver hilum, which might lead to granulation and fibrous scar obstructing the biliary ductules, or for increasing the biliary flow. Although recommended by several surgeons 727374, the use of corticosteroids remains controversial since their long-term benefit has not been proven; in addition there is a theoretical risk of exacerbating cholangitis. During the evaluation phase of biliary atresia, the infant's diet typically is not changed; post-operative breastfeeding is encouraged when possible, but an energetic supplementation may be required to obtain a 150 to 180 Kcal/kg/day intake. As long as cholestasis persists, supplementation in fat-soluble vitamins (ADEK) is needed.

Outcome after successful Kasai operation

If the Kasai operation succeeds in restoring bile flow, the stools become coloured and jaundice fades. This process may last several weeks or months. The evolution of the biliary cirrhosis is prevented or at least delayed; survival with the native liver has been reported up to adulthood (Figure 5) 7576.

Figure 5

Survival with native liver of 271 infants who underwent Kasai operation for biliary atresia between 1968 and 1983 at Bicêtre hospital (Paris) [75]*

Survival with native liver of 271 infants who underwent Kasai operation for biliary atresia between 1968 and 1983 at Bicêtre hospital (Paris) [75]*. * Lykavieris P, Chardot C, Sokhn M, Gauthier F, Valayer J, Bernard O: Outcome in adulthood of biliary atresia: a study of 63 patients who survived for over 20 years with their native liver. Hepatology 2005, 41: p. 367. Reproduction authorized by John Wiley and Sons, Inc.

The most common complications following the Kasai procedure include:

• Cholangitis

Direct communication of the intestine with the dystrophic intrahepatic bile ducts, together with poor bile flow, can cause an ascending bacterial cholangitis. This occurs particularly in the first weeks or months after the Kasai procedure in 30%-60% of cases 7778. This infection may be severe and sometimes fulminant. There are signs of sepsis (fever or hypothermia, impaired haemodynamic status), recurrent jaundice, acholic stools and perhaps abdominal pain. Diagnosis can be confirmed by analysis of blood cultures and/or liver biopsies 78. Treatment requires IV antibiotics and effective IV resuscitation. In the cases with recurrent and/or late cholangitis, obstruction of the Roux en Y loop or persisting colonisation of intrabiliary cyst should be considered. Recurrent cholangitis without a "surgical" cause may require continuous antibiotic prophylaxis.

• Portal hypertension

Portal hypertension occurs in at least two-thirds of the children after porto-enterostomy 7980, even in those with complete restoration of bile flow. The most common sites of varices include the oesophagus, stomach, Roux loop and anorectum. If the Kasai operation has clearly failed and the patient displays poor biochemical liver function and persisting jaundice, then liver transplantation is indicated. However, variceal sclerotherapy or band ligation before liver replacement may be necessary. In those cases with good liver function and absence of jaundice, endoscopic therapy may be the only treatment necessary 8182. Transjugular intrahepatic portosystemic shunts (TIPS) are rarely used for this indication due to the young age of the patients, the frequently observed hypoplasia of the portal vein and the possible development of intrahepatic biliary cavities 83. Surgical portosystemic shunts are nowadays rarely indicated, especially when transplantation is available, but should be considered when there is a normal liver function, non-progressive liver disease and life-threatening varices 84. Severe hypersplenism may exceptionally require splenic artery embolisation 85.

• Hepatopulmonary syndrome and pulmonary hypertension

Similarly to patients with other causes of spontaneous (cirrhosis or prehepatic portal hypertension) or acquired (surgical) portosystemic shunts, pulmonary arteriovenous shunts may occur even after complete clearance of jaundice (hepatopulmonary syndrome). Gut-derived vasoactive substances that are not cleared by the liver (due to the portosystemic shunts) may be responsible for this complication. Typically, hepatopulmonary syndrome causes hypoxia, cyanosis, dyspnoea and digital clubbing. Diagnosis is confirmed by pulmonary scintigraphy. Pulmonary hypertension can occur in cirrhotic children and may provoke syncope or even sudden death. Diagnosis of pulmonary hypertension is suggested by echocardiography. Liver transplantation reverses pulmonary shunts 86 and can reverse pulmonary hypertension (especially when diagnosed at an early stage) 87.

• Intrahepatic biliary cavities

Large intrahepatic biliary cysts may develop several months to years after the Kasai operation, even in patients with complete clearance of jaundice. These cavities may become infected and/or may compress the portal vein, requiring external drainage. Cystoenterostomy 88 or liver transplantation may eventually be required.

• Malignancies

Hepatocarcinomas, hepatoblastomas 89 and cholangiocarcinomas 90 have been described in the cirrhotic livers of patients with BA, in childhood or adulthood. Screening for malignancy has to be performed regularly in the follow-up of patients who underwent a successful Kasai operation.

Outcome after unsuccessful Kasai operation

If the Kasai operation fails to restore the bile flow, biliary cirrhosis progresses and necessitates liver transplantation. This is usually performed in the second year of life but may be necessary earlier (from 6 months of life) when there is a rapid aggravation of the liver disease. BA represents more than half of the indications for liver transplantation in childhood. Transplantation may also be required in those cases where recurrence of jaundice (secondary failure of the Kasai operation) or complications of cirrhosis (e.g. hepatopulmonary syndrome) occur despite an initially successful outcome after the Kasai operation.

There are two sources of liver grafts:

• Cadaveric donor: the graft is rarely a full size liver taken from a size-matched paediatric donor. More commonly, the graft consists of a left lobe (segments 2+3) or a left liver (2+3+4) obtained after reduction or splitting of an adult liver graft.

• Living-related donor: usually from one of the parents of the child.

Currently, patient survival at 5 and 10 years after liver transplantation is more than 80% 91929394. In most cases, the quality of life of the transplanted patient is close to normal. Normal somatic growth pattern and physical, sexual and intellectual maturity are usually achieved 959697.

Overall outcome of BA patients

The overall prognosis of BA patients has improved since the early days of paediatric liver transplantation. Nowadays about 90% of BA patients may hope to survive (Table 2), with a normal quality of life for most of them.

Table 2

Current prognosis of BA in France and the United Kingdom.

France 1997–2002 (271 patients)

UK 1999–2002 (148 patients) [98]

Overall 4-year patient survival

87%

89%

4-year survival with native liver after Kasai operation

43%

51%

4-year survival after liver transplantation

89%

90%

Several prognostic factors have been identified in BA patients. Some of them are related to characteristics of the disease (and cannot be altered): the prognosis of the Kasai operation is worse when BA is associated with a polysplenia syndrome 171899; when macroscopic obstructive lesions of extra-hepatic biliary remnant are diffuse (prognosis worsens from type 1 to type 4) 17555657; when histological obliteration of the bile ducts (especially at porta hepatis) is more severe 100101; and when liver fibrosis is more extensive at time of the Kasai operation (102–107). Other prognostic factors are related to the management of BA patients and can be improved:

• the chances of success of the Kasai operation decrease when the age at Kasai operation increases 17555759. It is, therefore, very important to diagnose BA early.

• accessibility to liver transplantation 108: the mortality while waiting for a liver graft has recently decreased due to the development of surgical techniques that increase the availability of liver grafts: liver graft splitting 109, living related liver donation 110.

• experience of the centre managing BA patients 717111. This point led the British health authorities to centralise all BA patients from England and Wales in three paediatric liver units 98. In France, a collaborative policy between centres was promoted and a national observatory of BA was created, in order to standardize therapeutic results nationwide and evaluate the results of this decentralized management.

Conclusion

With the sequential treatment including the Kasai operation in the first weeks of life and, in case of failure of this procedure, secondary liver transplantation, 90% of patients with BA can nowadays survive, with a normal quality of life for most of them. Early diagnosis and treatment by an experienced team provides children with the best chance of survival.

Links

French Observatory of Biliary Atresia: http://www.orpha.net/nestasso/OFAVB

European Federation for Biliary Atresia Research: http://www.orpha.net/nestasso/EFBAR

European Biliary Atresia Registry: http://www.biliary-atresia.com

Biliary Atresia Research Consortium: http://www.barcnetwork.org

Acknowledgements

To paediatricians and surgeons of the 45 centres participating in the studies of the French Observatory of Biliary Atresia.

Extrahepatic biliary atresia Alagille D Hepatology 1984 4 1 Suppl 7S 10S 6693074 Extrahepatic biliary atresia. Morphological study of 98 biliary remnants Gautier M Eliot N Arch Pathol Lab Med 1981 105 397 402 6894845 Surgical treatment of biliary atresia Kasai M Kimura S Asakura Y Suzuki Y Taira Y Obashi E J Pediatr Surg 1968 3 665 675 10.1016/0022-3468(68)90897-X Sequential treatment of biliary atresia with Kasai portoenterostomy and liver transplantation: a review Otte JB de Ville de Goyet J Reding R Hausleithner V Sokal E Chardot C Debande B Hepatology 1994 20 1 Pt 2 41S 48S 10.1016/0270-9139(94)90272-0 8005579 Time-space distribution of extrahepatic biliary atresia in The Netherlands and West Germany Houwen RH Kerremans I van Steensel-Moll HA van Romunde LK Bijleveld CM Schweizer P Z Kinderchir 1988 43 68 71 3388982 Epidemiology of biliary atresia in France: a national study 1986–96 Chardot C Carton M Spire-Bendelac N Le Pommelet C Golmard JL Auvert B J Hepatol 1999 31 1006 1013 10.1016/S0168-8278(99)80312-2 10604573 The frequency and outcome of biliary atresia in the UK and Ireland McKiernan PJ Baker AJ Kelly DA Lancet 2000 355 25 29 10.1016/S0140-6736(99)03492-3 10615887 Studies in the etiology of extrahepatic biliary atresia: time-space clustering Strickland AD Shannon K J Pediatr 1982 100 749 753 10.1016/S0022-3476(82)80576-3 7069535 Studies of the aetiology of neonatal hepatitis and biliary atresia Danks DM Campbell PE Jack I Rogers J Smith AL Arch Dis Child 1977 52 360 367 559475 Epidemiology of biliary atresia: a population-based study Yoon PW Bresee JS Olney RS James LM Khoury MJ Pediatrics 1997 99 376 382 10.1542/peds.99.3.376 9041292 Japanese biliary atresia registry Chiba T Ohi R Kamiyama T Nio M Ibrahim M Biliary atresia Tokyo (Japan): ICOM Associates Ohi R 1991 79 86 Racial influence on the incidence of biliary atresia Shim WK Kasai M Spence MA Prog Pediatr Surg 1974 6 53 62 4824812 Atrésie des voies biliaires en Polynésie française. Etude rétrospective de 10 ans Vic P Gestas P Mallet EC Arnaud JP Arch Pediatr 1994 1 646 651 7987462 Lack of evidence for seasonal variation in extrahepatic biliary atresia during infancy Ayas MF Hillemeier AC Olson AD J Clin Gastroenterol 1996 22 292 294 10.1097/00004836-199606000-00010 8771425 Epidemiologic study of infants with biliary atresia Davenport M Dhawan A Pediatrics 1998 101 729 230 10.1542/peds.101.4.729 9556409 Biliary atresia Howard ER Pediatric surgery and urology: long term outcomes London: WB Saunders Stringer MD, Oldham KT, Mouriquand PDE, Howard ER 1998 402 416 Prognosis of biliary atresia in the era of liver transplantation: French national study from 1986 to 1996 Chardot C Carton M Spire-Bendelac N Le Pommelet C Golmard JL Auvert B Hepatology 1999 30 606 611 10.1002/hep.510300330 10462364 Determinants of life span after Kasai operation at the era of liver transplantation Gauthier F Luciani JL Chardot C Branchereau S de Dreuzy O Lababidi A Montupet P Dubousset AM Huault G Bernard O Valayer J Tohoku J Exp Med 1997 181 97 107 10.1620/tjem.181.97 9149344 Prenatal detection of a cyst in the liver hilum. Interpretation for an adequate treatment Brunero M De Dreuzy O Herrera JM Gauthier F Valayer L Minerva Pediatr 1996 48 485 494 9064495 Antenatal presentation of biliary atresia Hinds R Davenport M Mieli-Vergani G Hadzic N J Pediatr 2004 144 43 46 10.1016/j.jpeds.2003.09.027 14722517 Microvillar enzyme assays in amniotic fluid and fetal tissues at different stages of development Muller F Oury JF Dumez Y Boue J Boue A Prenat Diagn 1988 8 189 198 2897684 Extrahepatic biliary atresia: a first-trimester event? Clues from light microscopy and immunohistochemistry Tan CE Driver M Howard ER Moscoso GJ J Pediatr Surg 1994 29 808 814 10.1016/0022-3468(94)90144-9 7521396 Ludwig symposium on biliary disorders-part I. Pathogenesis of ductal plate abnormalities Desmet VJ Mayo Clin Proc 1998 73 80 89 9443684 Anomalous development of the hepatobiliary system in the Inv mouse Mazziotti MV Willis LK Heuckeroth RO LaRegina MC Swanson PE Overbeek PA Perlmutter DH epatology 1999 30 H372 378 10.1002/hep.510300223 Contribution of hepatic parenchymal and nonparenchymal cells to hepatic fibrogenesis in biliary atresia Ramm GA Nair VG Bridle KR Shepherd RW Crawford DH Am J Pathol 1998 153 527 535 9708812 The viral association of neonatal cholestasis in Sweden: a possible link between cytomegalovirus infection and extrahepatic biliary atresia Fischler B Ehrnst A Forsgren M Orvell C Nemeth A J Pediatr Gastroenterol Nutr 1998 27 57 64 10.1097/00005176-199807000-00010 9669727 Neonatal hepatitis and extrahepatic biliary atresia associated with cytomegalovirus infection in twins Hart MH Kaufman SS Vanderhoof JA Erdman S Linder J Markin RS Kruger R Antonson DL Am J Dis Child 1991 145 302 305 1848391 Isolation of respiratory syncytial virus from liver tissue and extrahepatic biliary atresia material Nadal D Wunderli W Meurmann O Briner J Hirsig J Scand J Infect Dis 1990 22 91 93 2320967 The association of extrahepatic bile duct atresia and neonatal Epstein-Barr virus infection Weaver LT Nelson R Bell TM Acta Paediatr Scand 1984 73 155 157 6322509 Presence of human papillomavirus in extrahepatic biliary atresia Drut R Drut RM Gomez MA Cueto Rua E Lojo MM J Pediatr Gastroenterol Nutr 1998 27 530 535 10.1097/00005176-199811000-00007 9822318 Evaluation of the role of hepatitis C virus in biliary atresia A-Kader HH Nowicki MJ Kuramoto KI Baroudy B Zeldis JB Balistreri WF Pediatr Infect Dis J 1994 13 657 649 7970957 Negative serology for hepatitis A and B viruses in 18 cases of neonatal cholestasis Balistreri WF Tabor E Gerety RJ Pediatrics 1980 66 269 271 6250125 Comparative studies of biliary atresia in the human newborn and reovirus-induced cholangitis in weanling mice Bangaru B Morecki R Glaser JH Gartner LM Horwitz MS Lab Invest 1980 43 456 462 7421127 Extrahepatic biliary atresia in a rhesus monkey (Macaca mulatta) Rosenberg DP Morecki R Lollini LO Glaser J Cornelius CE Hepatology 1983 3 577 580 6862370 Role of reovirus type 3 in persistent infantile cholestasis Glaser JH Balistreri WF Morecki R J Pediatr 1984 105 912 915 10.1016/S0022-3476(84)80076-1 6502341 Biliary atresia and reovirus type 3 infection Morecki R Glaser JH Cho S Balistreri WF Horwitz MS N Engl J Med 1982 307 481 484 6285193 Detection of reovirus type 3 in the porta hepatis of an infant with extrahepatic biliary atresia: ultrastructural and immunocytochemical study Morecki R Glaser JH Johnson AB Kress Y Hepatology 1984 4 1137 1142 6389303 Detection of reovirus RNA in hepatobiliary tissues from patients with extrahepatic biliary atresia and choledochal cysts Tyler KL Sokol RJ Oberhaus SM Le M Karrer FM Narkewicz MR Tyson RW Murphy JR Low R Brown WR Hepatology 1998 27 1475 1482 10.1002/hep.510270603 9620316 Lack of correlation between infection with reovirus 3 and extrahepatic biliary atresia or neonatal hepatitis Brown WR Sokol RJ Levin MJ Silverman A Tamaru T Lilly JR Hall RJ Cheney M J Pediatr 1988 113 670 676 10.1016/S0022-3476(88)80376-7 2845040 Biliary atresia and reovirus type 3 infection Dussaix E Hadchouel M Tardieu M Alagille D N Engl J Med 1984 310 658 6319995 Reovirus 3 not detected by reverse transcriptase-mediated polymerase chain reaction analysis of preserved tissue from infants with cholestatic liver disease Steele MI Marshall CM Lloyd RE Randolph VE Hepatology 1995 21 697 702 10.1016/0270-9139(95)90520-0 7533124 New aspects in a murine model for extrahepatic biliary atresia Petersen C Biermanns D Kuske M Schakel K Meyer-Junghanel L Mildenberger H J Pediatr Surg 1997 32 1190 1195 10.1016/S0022-3468(97)90680-1 9269968 Treatment <it>of extrahepatic biliary atresia with interferon-alpha in a murine infectious model</it> Petersen C Bruns E Kuske M von Wussow P Pediatr Res 1997 42 623 628 9357935 Lack of evidence for rotavirus by polymerase chain reaction/enzyme immunoassay of hepatobiliary samples from children with biliary atresia Bobo L Ojeh C Chiu D Machado A Colombani P Schwarz K Pediatr Res 1997 41 229 234 9029644 Detection of group C rotavirus in infants with extrahepatic biliary atresia Riepenhoff-Talty M Gouvea V Evans MJ Svensson L Hoffenberg E Sokol RJ Uhnoo I Greenberg SJ Schakel K Zhaori G Fitzgerald J Chong S el-Yousef M Nemeth A Brown M Piccoli D Hyams J Ruffin D Rossi T J Infect Dis 1996 174 8 15 8656017 Idiopathic extrahepatic biliary atresia: recurrence in sibs in two families Cunningham ML Sybert VP Am J Med Genet 1988 31 421 426 10.1002/ajmg.1320310222 3232705 Recurrence of extrahepatic biliary atresia in two half sibs Gunasekaran TS Hassall EG Steinbrecher UP Yong SL Am J Med Genet 1992 43 592 594 10.1002/ajmg.1320430317 1605254 Familial extrahepatic biliary atresia Lachaux A Descos B Plauchu H Wright C Louis D Raveau J Hermier M J Pediatr Gastroenterol Nutr 1988 7 280 283 3351711 Extrahepatic biliary atresia and twinning Silveira TR Salzano FM Howard ER Mowat AP Braz J Med Biol Res 1991 24 67 71 1823220 Familial biliary atresia in three siblings including twins Smith BM Laberge JM Schreiber R Weber AM Blanchard H J Pediatr Surg 1991 26 1331 1333 10.1016/0022-3468(91)90613-X 1812269 Discordance for biliary atresia in two sets of monozygotic twins Hyams JS Glaser JH Leichtner AM Morecki R J Pediatr 1985 107 420 422 10.1016/S0022-3476(85)80524-2 2993572 Extrahepatic biliary atresia in twins: zygosity determination by short tandem repeat loci Poovorawan Y Chongsrisawat V Tanunytthawongse C Norapaksunthorn T Mutirangura A Chandrakamol B J Med Assoc Thai 1996 79 Suppl 1 S119 S124 9071076 Biliary atresia in two sets of twins Strickland AD Shannon K Coln CD J Pediatr 1985 107 418 420 10.1016/S0022-3476(85)80523-0 4040965 Association between HLA and extrahepatic biliary atresia Silveira TR Salzano FM Donaldson PT Mieli-Vergani G Howard ER Mowat AP J Pediatr Gastroenterol Nutr 1993 16 114 117 8450374 A multivariable risk factor analysis of the portoenterostomy (Kasai) procedure for biliary atresia: twenty-five years of experience from two centers Altman RP Lilly JR Greenfeld J Weinberg A van Leeuwen K Flanigan L Ann Surg 1997 226 348 355 1191037 9339941 10.1097/00000658-199709000-00014 Japanese Biliary Atresia Registry, 1989 to 1994 Ibrahim M Miyano T Ohi R Saeki M Shiraki K Tanaka K Kamiyama T Nio M Tohoku J Exp Med 1997 181 85 95 10.1620/tjem.181.85 9149343 Biliary atresia registry, 1976 to 1989 Karrer FM Lilly JR Stewart BA Hall RJ J Pediatr Surg 1990 25 1076 1081 10.1016/0022-3468(90)90222-U 2262862 Plaidoyer pour un diagnostic précoce de l'atrésie des voies biliaires. Douze erreurs à éviter Bernard O Arch Pediatr 1995 2 937 939 10.1016/0929-693X(96)89888-5 7496470 Late referral for biliary atresia – missed opportunities for effective surgery Mieli-Vergani G Howard ER Portman B Mowat AP Lancet 1989 1 421 423 10.1016/S0140-6736(89)90012-3 2563796 Diagnostic utility of hepatobiliary scintigraphy with 99mTc-DISIDA in neonatal cholestasis Spivak W Sarkar S Winter D Glassman M Donlon E Tucker KJ J Pediatr 1987 110 855 861 10.1016/S0022-3476(87)80396-7 3585600 Diagnostic précoce des cholestases néonatales Bernard O Arch Pediatr 1998 5 1031 1035 10.1016/S0929-693X(98)80020-1 9789639 Progrès récents en hépatologie pédiatrique Bernard O Gauthier F Arch Fr Pediatr 1991 48 53 56 2018425 Antenatal diagnosis of congenital anomalies of the biliary tract Redkar R Davenport M Howard ER J Pediatr Surg 1998 33 700 704 10.1016/S0022-3468(98)90190-7 9607471 Nonvisualization of the fetal gallbladder in early pregnancy: comparison with clinical outcome Blazer S Zimmer EZ Bronshtein M Radiology 2002 224 379 382 12147832 Prenatal diagnosis of cardiosplenic syndromes: a 10-year experience Berg C Geipel A Smrcek J Krapp M Germer U Kohl T Gembruch U Baschat AA Ultrasound Obstet Gynecol 2003 22 451 459 10.1002/uog.904 14618656 Color Doppler of the splenic artery in the prenatal diagnosis of heterotaxic syndromes Abuhamad AZ Robinson JN Bogdan D Tannous RJ Am J Perinatol 1999 16 469 473 10774762 Prenatal diagnosis of interrupted inferior vena cava as an isolated finding: a benign vascular malformation Celentano C Malinger G Rotmensch S Gerboni S Wolman Y Glezerman M Ultrasound Obstet Gynecol 1999 14 215 218 10.1046/j.1469-0705.1999.14030215.x 10550884 Atrésie des voies biliaires Valayer J Chardot C Encyclopédie Médico Chirurgicale. Techniques chirurgicales – appareil digestif (40–890); 2002 1 11 Second operation for repair of biliary atresia Freitas L Gauthier F Valayer J J Pediatr Surg 1987 22 857 860 3668778 Hepatic portocholecystostomy for biliary atresia Lilly JR J Pediatr Surg 1979 14 301 314 480091 Catheter decompression of hepatic portocholecystostomy Lilly JR Stellin G J Pediatr Surg 1982 17 904 905 6761422 Surgical management of intractable cholangitis following successful Kasai procedure Altman RP Anderson KD J Pediatr Surg 1982 17 894 900 7161677 Corticosteroid therapy in biliary atresia Karrer FM Lilly JR J Pediatr Surg 1985 20 693 695 4087100 Technique and results of operative management of biliary atresia Kasai M Suzuki H Ohashi E Ohi R Chiba T Okamoto A World J Surg 1978 2 571 579 10.1007/BF01556048 741761 Outcome in adulthood of biliary atresia: a study of 63 patients who survived for over 20 years with their native liver Lykavieris P Chardot C Sokhn M Gauthier F Valayer J Bernard O Hepatology 2005 41 366 371 10.1002/hep.20547 15660386 Long-term follow-up after surgery for patients with biliary atresia Ohi R Nio M Chiba T Endo N Goto M Ibrahim M J Pediatr Surg 1990 25 442 445 10.1016/0022-3468(90)90390-U 2329462 Influence of diversion on the development of cholangitis after hepatoportoenterostomy for biliary atresia Burnweit CA Coln D J Pediatr Surg 1986 21 1143 1146 10.1016/0022-3468(86)90028-X 3794981 Bacterial cholangitis after surgery for biliary atresia Ecoffey C Rothman E Bernard O Hadchouel M Valayer J Alagille D J Pediatr 1987 111 824 849 10.1016/S0022-3476(87)80195-6 3681545 Changes of portal vein pressure and intrahepatic blood vessels after surgery for biliary atresia Kasai M Okamoto A Ohi R Yabe K Matsumura Y J Pediatr Surg 1981 16 152 159 7241316 Portal hypertension after successful hepatic portoenterostomy in biliary atresia Ohi R Mochizuki I Komatsu K Kasai M J Pediatr Surg 1986 21 271 274 3958889 Endoscopic variceal ligation in the management of gastroesophageal varices in postoperative biliary atresia Sasaki T Hasegawa T Nakajima K Tanano H Wasa M Fukui Y Okada A J Pediatr Surg 1998 33 1628 1632 10.1016/S0022-3468(98)90595-4 9856881 Endoscopic sclerotherapy in the management of esophageal varices in 61 children with biliary atresia Stringer MD Howard ER Mowat AP J Pediatr Surg 1989 24 438 442 2786958 The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art Rossle M Siegerstetter V Huber M Ochs A Liver 1998 18 73 89 9588766 Portal hypertension: porto systemic shunts Valayer J Branchereau S Pediatric surgery and urology: long term outcomes London: W.B. Saunders Stringer MD, Oldham KT, Mouriquand PDE, Howard ER 1998 439 446 Partial splenic embolization for hypersplenism in pediatric patients with special reference to its long-term efficacy Chiba T Ohi R Yaoita M Biliary atresia Tokyo: ICOM Associates Inc Ohi R 1991 154 158 Intrapulmonary shunting in biliary atresia before and after living-related liver transplantation Yonemura T Yoshibayashi M Uemoto S Inomata Y Tanaka K Furusho K Br J Surg 1999 86 1139 1143 10.1046/j.1365-2168.1999.01207.x 10504366 Early liver transplantation is crucial in children with liver disease and pulmonary artery hypertension Losay J Piot D Bougaran J Ozier Y Devictor D Houssin D Bernard O J Hepatol 1998 28 337 342 10.1016/0168-8278(88)80022-9 9514547 Cystic dilatation of the intrahepatic biliary system in biliary atresia after hepatic portoenterostomy Tsuchida Y Honna T Kawarasaki H J Pediatr Surg 1994 29 630 634 10.1016/0022-3468(94)90728-5 8035271 Liver transplantation for biliary atresia associated with malignant hepatic tumors Tatekawa Y Asonuma K Uemoto S Inomata Y Tanaka K J Pediatr Surg 2001 36 436 439 10.1053/jpsu.2001.21600 11226990 Cholangiocarcinoma associated with biliary cirrhosis due to congenital biliary atresia Kulkarni PB Beatty E Jr Am J Dis Child 1977 131 442 444 192070 PELD score and posttransplant outcome in pediatric liver transplantation: a retrospective study of 100 recipients Bourdeaux C Tri TT Gras J Sokal E Otte JB de Ville de Goyet J Reding R Transplantation 2005 79 1273 1276 10.1097/00007890-200505150-00060 15880084 Pediatric liver transplantation for biliary atresia: results of primary grafts in 328 recipients Diem HV Evrard V Vinh HT Sokal EM Janssen M Otte JB Reding R Transplantation 2003 75 1692 1697 10.1097/01.TP.0000062570.83203.A3 12777858 Long-term outcome of pediatric liver transplantation for biliary atresia: a 10-year follow-up in a single center Fouquet V Alves A Branchereau S Grabar S Debray D Jacquemin E Devictor D Durand P Baujard C Fabre M Pariente D Chardot C Dousset B Massault PP Bernard D Houssin D Bernard O Gauthier F Soubrane O Liver Transpl 2005 11 152 160 10.1002/lt.20358 15666395 Biliary atresia: clinical profiles, risk factors, and outcomes of 755 patients listed for liver transplantation Utterson EC Shepherd RW Sokol RJ Bucuvalas J Magee JC McDiarmid SV Anand R The Split Research Group J Pediatr 2005 147 180 185 10.1016/j.jpeds.2005.04.073 16126046 Growth and quality of life after living-related liver transplantation in children Asonuma K Inomata Y Uemoto S Egawa H Kiuchi T Okajima H Shapiro AM Tanaka K Pediatr Transplant 1998 2 64 69 10084763 Long-term follow-up of growth in height after successful liver transplantation Codoner-Franch P Bernard O Alvarez F J Pediatr 1994 124 368 373 10.1016/S0022-3476(94)70357-4 8120704 Health-related quality of life in long-term survivors of pediatric liver transplantation Midgley DE Bradlee TA Donohoe C Kent KP Alonso EM Liver Transpl 2000 6 333 639 10.1053/lv.2000.6139 10827235 Seamless management of biliary atresia in England and Wales (1999–2002) Davenport M De Ville de Goyet J Stringer MD Mieli-Vergani G Kelly DA McClean P Spitz L Lancet 2004 363 1354 1357 10.1016/S0140-6736(04)16045-5 15110492 Biliary atresia and the polysplenia syndrome: its impact on final outcome Vazquez J Lopez Gutierrez JC Gamez M Lopez-Santamaria M Murcia J Larrauri J Diaz MC Jara P Tovar JA J Pediatr Surg 1995 30 485 487 10.1016/0022-3468(95)90062-4 7760248 Anatomy of the porta hepatis (PH) as rational basis for the hepatoporto-enterostomy (HPE) Schweizer P Kirschner HJ Schittenhelm C Eur J Pediatr Surg 1999 9 13 18 10207697 Does the morphology of the extrahepatic biliary remnants in biliary atresia influence survival? A review of 205 cases Tan CE Davenport M Driver M Howard ER J Pediatr Surg 1994 29 1459 1464 10.1016/0022-3468(94)90144-9 7844721 Indication for portoenterostomy based on 103 patients with Suruga II modification Ohya T Miyano T Kimura K J Pediatr Surg 1990 25 801 804 2380901 Prognosis of extrahepatic bile-duct atresia after hepatoportoenterostomy Schweizer P Schweizer M Schellinger K Kirschner HJ Schittenhelm C Pediatr Surg Int 2000 16 351 355 10.1007/s003830000385 10955561 Proposal of fibrosis index using image analyzer as a quantitative histological evaluation of liver fibrosis in biliary atresia Tanano H Hasegawa T Kimura T Sasaki T Kawahara H Kubota A Okada A Pediatr Surg Int 2003 19 52 56 12721724 Biliary atresia: early determination of prognosis Vazquez-Estevez J Stewart B Shikes RH Hall RJ Lilly JR J Pediatr Surg 1989 24 48 50 2723994 Hepatic fibrosis and survival in biliary atresia Weerasooriya VS White FV Shepherd RW J Pediatr 2004 144 123 125 10.1016/j.jpeds.2003.09.042 14722530 The Kasai portoenterostomy for biliary atresia: A review of a 27-year experience with 81 patients Wildhaber BE Coran AG Drongowski RA Hirschl RB Geiger JD Lelli JL Teitelbaum DH J Pediatr Surg 2003 38 1480 1485 10.1016/S0022-3468(03)00499-8 14577071 Five- and 10-year survival rates after surgery for biliary atresia: a report from the Japanese Biliary Atresia Registry Nio M Ohi R Miyano T Saeki M Shiraki K Tanaka K J Pediatr Surg 2003 38 997 1000 10.1016/S0022-3468(03)00178-7 12861525 Split-liver transplantation eliminates the need for living-donor liver transplantation in children with end-stage cholestatic liver disease Gridelli B Spada M Petz W Bertani A Lucianetti A Colledan M Altobelli M Alberti D Guizzetti M Riva S Melzi ML Stroppa P Torre G Transplantation 2003 75 1197 1203 10.1097/01.TP.0000061940.96949.A1 12717203 Living-related liver transplantation in children at Saint-Luc University Clinics: a seven year experience in 77 recipients Reding R Chardot C Paul K Veyckemans F Van Obbergh L De Clety SC Detaille T Clapuyt P Saint-Martin C Janssen M Lerut J Sokal E Otte JB Acta Chir Belg 2001 101 17 19 11301941 Results of surgical treatment for extrahepatic biliary atresia in United Kingdom 1980-2. Survey conducted on behalf of the British Paediatric Association Gastroenterology Group and the British Association of Paediatric Surgeons McClement JW Howard ER Mowat AP Br Med J (Clin Res Ed) 1985 290 345 347 1417374 3917813